Predictors of clinical outcome in patients receiving local intra-arterial thrombolysis without subsequent symptomatic intracranial hemorrhage against acute middle cerebral artery occlusion

American Journal of Neuroradiology

Volumn 25, Issue 10, 2004, Pages 1796-1801

  Takada, Tatsuro ^a   Yasaka, Masahiro ^a   Minematsu, Kazuo ^a   Naritomi, Hiroaki ^a   Yamaguchi, Takenori ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE DISEASE; ANAMNESIS; ARTICLE; BLOOD CLOT LYSIS; BLOOD PRESSURE; BRAIN ANGIOGRAPHY; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE DURATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; LOCAL THERAPY; LOGISTIC REGRESSION ANALYSIS; MEDICAL ASSESSMENT; MIDDLE CEREBRAL ARTERY OCCLUSION; RANKIN SCALE; SCORING SYSTEM; STROKE; SUDDEN DEATH; TREATMENT OUTCOME; UNIVARIATE ANALYSIS; AGED; CEREBRAL ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; FEMALE; HOSPITALIZATION; INTRAARTERIAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; STATISTICAL MODEL; TIME;

AGED; CEREBROVASCULAR ACCIDENT; FEMALE; FIBRINOLYTIC AGENTS; HOSPITALIZATION; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; INJECTIONS, INTRA-ARTERIAL; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 16644370807     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587
2. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-1025
3. Albers GW, Clark WM, Madden KP, et al. ATLANTIS trial: results for patients treated within 3 hours of stroke onset: alteplase thrombolysis for acute noninterventional therapy in ischemic Stroke. Stroke 2002;33:493-495
4. Adams HP Jr, Brott TG, Furlan AJ, et al. Guidelines for thrombolytic therapy for acute Stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Stroke 1996;27:1711-1718
5. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: The PROACT II study: a randomized controlled trial: prolyse in acute cerebral thromboembolism. JAMA 1999;282:2003-2011
6. Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II): Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245-1251
7. Levy DE, Brott TG, Haley EC Jr, et al. Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. Stroke 1994;25:291-297
8. Kidwell CS, Saver JL, Carneado J, et al. Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis. Stroke 2002;33:717-724
9. Moulin T, Cattin F, Crepin-Leblond T, et al. Early CT signs in acute middle cerebral artery infarction: predictive value for subsequent infarct locations and outcome. Neurology 1996;47:366-375
10. Mori E, Yoneda Y, Tabuchi M, et al. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 1992;42:976-982
11. Yamaguchi T, Hayakawa T, Kikuchi H, et al. Intravenous tissue plasminogen activator ameliorates the outcome of hyperacute embolic stroke. Cerebrovasc Dis 1993;3:269-272
12. Bendszus M, Urbach H, Ries F, et al. Outcome after local intraarterial fibrinolysis compared with the natural course of patients with a dense middle cerebral artery on early CT. Neuroradiology 1998;40:54-58
13. Arnold M, Schroth G, Nedeltchev K, et al. Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion. Stroke. 2002;33:1828-1833
14. Wechsler LR, Roberts R, Furlan AJ, et al. Factors influencing outcome and treatment effect in PROACT II. Stroke 2003;34:1224-1229
15. Aronowski J, Strong R, Shirzadi A, et al. Ethanol plus caffeine (caffeinol) for treatment of ischemic stroke: preclinical experience. Stroke 2003;34:1246-1251
16. Gönner F, Remonda L, Mattle H, et al. Local intra-arterial thrombolysis in acute ischemic stroke. Stroke 1998;29:1894-1900